Study details
Enrolling now
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Northwestern University
NCT IDNCT05990426ClinicalTrials.gov data as of Apr 2026
Target enrollment
30
Study length
about 2.9 years
Ages
18+
Sex
Female only
Locations
1 site in IL
What this study is about
Researchers are testing whether alternate day fasting can help reduce side effects during chemotherapy treatment for endometrial, ovarian, and uterine cancers. The trial is testing a behavioral intervention called FAST.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in FAST Intervention
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: Adverse events and toxicity, Neuropathic Pain, Physical Function
Body systems
Oncology